BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type Psoriasis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
The clinical objective of this study was to determine the effect of BIRB 796 BS on pharmacodynamic markers of psoriasis as a measure of efficacy, to determine the population pharmacokinetics of BIRB 796 BS and to determine the safety of BIRB 796 BS over 4 weeks of treatment in patients with moderate to severe plaque-type psoriasis.
Epistemonikos ID: cef8b13ee9b975c56d7be494a5769a44e14744bc
First added on: May 12, 2024